Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03800745Phase 4Completed
A Phase 4 trial of docusate sodium, polyethylene glycol 3350 in Gastrointestinal Dysmotility, sponsored by Cleveland Clinic. Started Nov 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03800745.